Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

FDA Drug Recalls

18,003 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

ePHEDrine Sulfate

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-891-61 D-0943-2018
Class II · Moderate risk

0.2% ROPivacaine

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 15082-002-87 D-0942-2018
Class II · Moderate risk

PHENYLephrine 40 mg

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-893-25 D-0940-2018
Class II · Moderate risk

NORepiNEPHrine 8 mg

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-815-25 D-0939-2018
Class II · Moderate risk

MORphine 1 mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-241-10 D-0938-2018
Class II · Moderate risk

Midazolam 1 mg/mL

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 4252-401-10 D-0937-2018
Class II · Moderate risk

Heparin 25

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-729-25 D-0934-2018
Class II · Moderate risk

EPINEPHrine

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-823-25 D-0932-2018
Class II · Moderate risk

EPINEPHrine

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 15082-855-25 D-0931-2018
Class II · Moderate risk

ePHEDrine 50mg

Lack of Assurance of Sterility: Potential leakage of bags.

Terminated Sterility / contamination Avella of Deer Valley, Inc. Store 38 NDC 42852-805-61 D-0930-2018
Class II · Moderate risk

Monsel's Solution

CGMP Deviations: Products not manufactured under current good manufacturing practices.

Terminated cGMP deviation BioDiagnostic International NDC 42721-112-08 D-0874-2018
Class III · Low risk

Maxzide-25

Superpotent Drug: Composite assay results obtained during routine stability testing were slightly above specification.

Terminated Wrong potency / content Mylan Pharmaceuticals Inc. NDC 0378-0464-01 D-0877-2018

Recalls by year